IREN – IREN Ltd

IREN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

30.42

Margin Of Safety %

Put/Call OI Ratio

1.05

EPS Next Q Diff

-0.01

EPS Last/This Y

-2.46

EPS This/Next Y

1.22

Price

41.25

Target Price

84.64

Analyst Recom

1.71

Performance Q

-27.42

Upside

-56.7%

Beta

4.28

Ticker: IREN

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	IREN	39.02	0.94	1.26	2533290
2026-07-14	IREN	38.78	1.01	0.96	2649173
2026-07-15	IREN	38.36	1.03	0.67	2745905
2026-07-16	IREN	34.94	1.06	1.40	2829182
2026-07-17	IREN	33.59	1.10	1.37	2892695
2026-07-20	IREN	40.3	1.09	0.67	2398447
2026-07-21	IREN	41.19	1.05	1.01	2571692
2026-07-22	IREN	41.15	1.06	1.24	2649855
2026-07-23	IREN	40.71	1.09	0.87	2703755
2026-07-24	IREN	37.07	1.10	1.93	2762759
2026-07-27	IREN	36.5	1.13	0.72	2522733
2026-07-28	IREN	34.07	1.11	0.63	2577261
2026-07-29	IREN	29.42	1.11	0.73	2627993
2026-07-30	IREN	38.68	1.07	0.86	2719199
2026-07-31	IREN	36.67	1.08	1.67	2845390
2026-08-03	IREN	39.75	1.02	0.87	2504435
2026-08-04	IREN	40.77	1.00	1.06	2663598
2026-08-05	IREN	38.62	1.03	0.77	2755036
2026-08-06	IREN	37.85	1.04	0.55	2784892
2026-08-07	IREN	41.34	1.05	0.63	2823374
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	IREN	38.98	-100.0	50.9	-2.02
2026-07-14	IREN	38.60	-100.0	60.8	-2.02
2026-07-15	IREN	38.27	-100.0	61.1	-2.02
2026-07-16	IREN	34.82	-100.0	42.4	-2.02
2026-07-17	IREN	33.60	-100.0	55.1	-2.02
2026-07-20	IREN	40.26	-100.0	108.0	-2.02
2026-07-21	IREN	41.30	-100.0	69.5	-2.02
2026-07-22	IREN	41.31	-100.0	63.1	-2.02
2026-07-23	IREN	40.59	-100.0	-884.0	-2.02
2026-07-24	IREN	37.05	-100.0	-840.4	-2.02
2026-07-27	IREN	36.26	-100.0	-881.1	-2.02
2026-07-28	IREN	33.98	-100.0	-855.4	-2.02
2026-07-29	IREN	29.32	-100.0	-812.0	-2.02
2026-07-30	IREN	38.31	-100.0	-1077.5	-2.02
2026-07-31	IREN	36.82	-100.0	-871.2	-2.05
2026-08-03	IREN	39.76	-100.0	-943.7	-2.05
2026-08-04	IREN	39.76	-100.0	-943.7	-2.05
2026-08-05	IREN	38.94	-100.0	-865.3	-2.05
2026-08-06	IREN	37.92	-100.0	-878.3	-2.05
2026-08-07	IREN	41.25	-100.0	-948.7	-2.05
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	IREN	-0.02	4.81	24.68
2026-07-14	IREN	-0.02	4.81	24.68
2026-07-15	IREN	-0.02	4.81	24.68
2026-07-16	IREN	-0.02	4.81	24.68
2026-07-17	IREN	-0.02	4.81	24.68
2026-07-20	IREN	-0.02	4.69	24.68
2026-07-21	IREN	-0.02	4.69	24.68
2026-07-22	IREN	-0.02	4.69	24.68
2026-07-23	IREN	-0.02	4.69	24.68
2026-07-24	IREN	-0.02	4.69	24.68
2026-07-27	IREN	-0.02	4.46	30.42
2026-07-28	IREN	-0.02	4.46	30.42
2026-07-29	IREN	-0.02	4.46	30.42
2026-07-30	IREN	-0.02	4.46	30.42
2026-07-31	IREN	-0.02	4.46	30.42
2026-08-03	IREN	-0.02	5.22	30.42
2026-08-04	IREN	-0.02	5.22	30.42
2026-08-05	IREN	-0.02	5.22	30.42
2026-08-06	IREN	-0.02	5.22	30.42
2026-08-07	IREN	-0.02	5.22	30.42
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.25

Avg. EPS Est. Current Quarter

-0.58

Avg. EPS Est. Next Quarter

-0.26

Insider Transactions

-0.02

Institutional Transactions

5.22

Beta

4.28

Average Sales Estimate Current Quarter

162

Average Sales Estimate Next Quarter

271

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

46.3

Max Drawdown 5-Year %

Target Price

84.64

P/E

81.51

Forward P/E

PEG

P/S

19.45

P/B

5.28

P/Free Cash Flow

EPS

0.51

Average EPS Est. Cur. Y

-2.05

EPS Next Y. (Est.)

-0.83

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

20.91

Relative Volume

0.63

Return on Equity vs Sector %

-6.1

Return on Equity vs Industry %

-10.2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

-948.7

◆ IREN Financial

$41.26

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

9/25

Volume

6/15

Valuation

12/20

TP/AR

1/10

Options

3/10

RSI

Range 1M

70.3%

Sup Dist

11.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

11/30

Estimates

5/20

Inst/Vol

6/15

Options

5/10

EPS Yr

-277.5%

EPS NY

71%

52W%

39.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +105.1% upside

Quality

3/30

Valuation

14/30

Growth

8/25

Stability

4/10

LT Trend

0/5

Upside

+105.1%

Quality

IREN — P/E HistoricalCapital Markets

IREN LIMITED

Sector: Financial Services

Industry: Capital Markets

Employees: 257

IREN Limited operates in the vertically integrated data center business in Australia and Canada. The company owns and operates computing hardware, as well as electrical infrastructure and data centers. It also mines Bitcoin, a scarce digital asset that is created and transmitted through the operation of a peer-to-peer network of computers running the Bitcoin software. The company was formerly known as Iris Energy Limited and changed its name to IREN Limited in November 2024. The company was incorporated in 2018 and is based in Sydney, Australia.

IREN

Latest News

—

Caricamento notizie per IREN…

stock quote shares IREN – IREN Ltd Stock Price stock today

news today IREN – IREN Ltd stock forecast ,stock prediction 2023 2024 2025

marketwatch IREN – IREN Ltd yahoo finance google finance

stock history IREN – IREN Ltd invest stock market

stock prices IREN premarket after hours

ticker IREN fair value insiders trading

IMRN – Immuron Limited ADR

IMRN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.43

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

0.62

EPS This/Next Y

Price

1.03

Target Price

Analyst Recom

Performance Q

32.53

Upside

-667.3%

Beta

1.1

Ticker: IMRN

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	IMRN	1.25	N/A	N/A	0
2026-07-14	IMRN	1.24	N/A	N/A	0
2026-07-15	IMRN	1.1901	N/A	N/A	0
2026-07-16	IMRN	1.11	N/A	N/A	0
2026-07-17	IMRN	1.185	N/A	N/A	0
2026-07-20	IMRN	1.14	N/A	N/A	0
2026-07-21	IMRN	1.16	N/A	N/A	0
2026-07-22	IMRN	1.11	N/A	N/A	0
2026-07-23	IMRN	1.1	N/A	N/A	0
2026-07-24	IMRN	1.1	N/A	N/A	0
2026-07-27	IMRN	1.12	N/A	N/A	0
2026-07-28	IMRN	1.09	N/A	N/A	0
2026-07-29	IMRN	1.095	N/A	N/A	0
2026-07-30	IMRN	1.11	N/A	N/A	0
2026-07-31	IMRN	1.07	N/A	N/A	0
2026-08-03	IMRN	1.05	N/A	N/A	0
2026-08-04	IMRN	1.08	N/A	N/A	0
2026-08-05	IMRN	1.07	N/A	N/A	0
2026-08-07	IMRN	1.03	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	IMRN	1.29	-	-	-0.01
2026-07-14	IMRN	1.25	-	-	-0.01
2026-07-15	IMRN	1.20	-	-	-0.01
2026-07-16	IMRN	1.08	-	-	-0.01
2026-07-17	IMRN	1.17	-	-	-0.01
2026-07-20	IMRN	1.16	-	-	-0.01
2026-07-21	IMRN	1.22	-	-	-0.01
2026-07-22	IMRN	1.13	-	-	-0.01
2026-07-23	IMRN	1.12	-	-	-0.01
2026-07-24	IMRN	1.11	-	-	-0.01
2026-07-27	IMRN	1.09	-	-	-0.01
2026-07-28	IMRN	1.10	-	-	-0.01
2026-07-29	IMRN	1.10	-	-	-0.01
2026-07-30	IMRN	1.13	-	-	-0.01
2026-07-31	IMRN	1.08	-	-	-0.01
2026-08-03	IMRN	1.06	-	-	-0.01
2026-08-04	IMRN	1.06	-	-	-0.01
2026-08-05	IMRN	1.13	-	-	-0.01
2026-08-06	IMRN	1.09	-	-	-0.01
2026-08-07	IMRN	1.03	-	-	-0.01
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	IMRN	0	61.13	2.27
2026-07-14	IMRN	0	61.13	2.27
2026-07-15	IMRN	0	61.13	2.27
2026-07-16	IMRN	0	61.13	2.27
2026-07-17	IMRN	0	61.13	2.27
2026-07-20	IMRN	0	59.14	2.27
2026-07-21	IMRN	0	59.14	2.27
2026-07-22	IMRN	0	59.14	2.27
2026-07-23	IMRN	0	59.14	2.27
2026-07-24	IMRN	0	59.14	2.27
2026-07-27	IMRN	0	482.73	2.43
2026-07-28	IMRN	0	482.73	2.43
2026-07-29	IMRN	0	482.73	2.43
2026-07-30	IMRN	0	482.73	2.43
2026-07-31	IMRN	0	482.73	2.43
2026-08-03	IMRN	0	6.10	2.43
2026-08-04	IMRN	0	6.10	2.43
2026-08-05	IMRN	0	6.10	2.43
2026-08-06	IMRN	0	6.10	2.43
2026-08-07	IMRN	0	6.10	2.43
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

6.1

Beta

1.1

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

82.7

Max Drawdown 5-Year %

-85.6

Target Price

P/E

Forward P/E

PEG

P/S

1.84

P/B

1.03

P/Free Cash Flow

EPS

-0.48

Average EPS Est. Cur. Y

-0.01

EPS Next Y. (Est.)

-0.02

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-61.85

Relative Volume

0.03

Return on Equity vs Sector %

-62.9

Return on Equity vs Industry %

-46.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ IMRN Healthcare

$1.10

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

22/25

Volume

11/15

Valuation

12/20

TP/AR

1/10

Options

0/10

RSI

47.4

Range 1M

2.9%

Sup Dist

3.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

17/30

Estimates

2/20

Inst/Vol

8/15

Options

0/10

EPS Yr

98.6%

EPS NY

-26.9%

52W%

20.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +263.6% upside

Quality

6/30

Valuation

16/30

Growth

10/25

Stability

7/10

LT Trend

3/5

Upside

+263.6%

Quality

IMRN — P/E HistoricalBiotechnology

Immuron Limited

Sector: Healthcare

Industry: Biotechnology

Employees: 7

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers' diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. In additon, the company develops IMM-986, that is in pre-clinical stage. Further, it offers technology platform. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.

IMRN

Latest News

—

Caricamento notizie per IMRN…

stock quote shares IMRN – Immuron Limited ADR Stock Price stock today

news today IMRN – Immuron Limited ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch IMRN – Immuron Limited ADR yahoo finance google finance

stock history IMRN – Immuron Limited ADR invest stock market

stock prices IMRN premarket after hours

ticker IMRN fair value insiders trading

IMMP – Immutep Limited ADR

IMMP — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.47

Margin Of Safety %

Put/Call OI Ratio

0.05

EPS Next Q Diff

EPS Last/This Y

-0.02

EPS This/Next Y

0.12

Price

0.39

Target Price

0.89

Analyst Recom

2.33

Performance Q

-10.78

Upside

-3,420.5%

Beta

2.21

Ticker: IMMP

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	IMMP	0.4501	0.02	0.00	7145
2026-07-14	IMMP	0.4367	0.02	0.14	7305
2026-07-15	IMMP	0.4399	0.02	0.81	7336
2026-07-16	IMMP	0.4403	0.03	0.08	7365
2026-07-17	IMMP	0.4182	0.03	0.00	7506
2026-07-20	IMMP	0.41	0.03	0.06	3123
2026-07-21	IMMP	0.3999	0.03	0.47	3349
2026-07-22	IMMP	0.3891	0.03	3.67	3384
2026-07-23	IMMP	0.399	0.05	2.33	3444
2026-07-24	IMMP	0.3875	0.03	2.75	3384
2026-07-27	IMMP	0.3858	0.03	1.50	3390
2026-07-28	IMMP	0.381	0.04	0.00	3444
2026-07-29	IMMP	0.38	0.03	1.48	3413
2026-07-30	IMMP	0.3833	0.04	3.58	3458
2026-07-31	IMMP	0.3874	0.03	1.41	3439
2026-08-03	IMMP	0.3844	0.04	1.76	3448
2026-08-04	IMMP	0.395	0.05	0.04	3482
2026-08-05	IMMP	0.3846	0.04	0.31	3506
2026-08-07	IMMP	0.388	0.05	1.39	3566
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	IMMP	0.45	-	59.6	-0.32
2026-07-14	IMMP	0.44	-	59.8	-0.32
2026-07-15	IMMP	0.44	-	59.8	-0.32
2026-07-16	IMMP	0.44	-	59.6	-0.32
2026-07-17	IMMP	0.42	-	59.7	-0.32
2026-07-20	IMMP	0.41	-	60.2	-0.32
2026-07-21	IMMP	0.40	-	60.3	-0.32
2026-07-22	IMMP	0.39	-	60.5	-0.32
2026-07-23	IMMP	0.39	-	60.6	-0.32
2026-07-24	IMMP	0.39	-	60.6	-0.32
2026-07-27	IMMP	0.38	-	60.6	-0.32
2026-07-28	IMMP	0.38	-	60.7	-0.32
2026-07-29	IMMP	0.38	-	60.7	-0.32
2026-07-30	IMMP	0.39	-	60.5	-0.32
2026-07-31	IMMP	0.39	-	60.5	-0.32
2026-08-03	IMMP	0.38	-	60.8	-0.32
2026-08-04	IMMP	0.38	-	60.8	-0.32
2026-08-05	IMMP	0.38	-	60.8	-0.32
2026-08-06	IMMP	0.37	-	60.8	-0.32
2026-08-07	IMMP	0.39	-	61.3	-0.32
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	IMMP	0.00	-58.78	2.67
2026-07-14	IMMP	0.00	-58.78	2.67
2026-07-15	IMMP	0.00	-58.78	2.67
2026-07-16	IMMP	0.00	-58.78	2.67
2026-07-17	IMMP	0.00	-58.78	2.67
2026-07-20	IMMP	0.00	-58.62	2.67
2026-07-21	IMMP	0.00	-58.62	2.67
2026-07-22	IMMP	0.00	-58.62	2.67
2026-07-23	IMMP	0.00	-58.62	2.67
2026-07-24	IMMP	0.00	-58.62	2.67
2026-07-27	IMMP	0.00	-58.06	1.47
2026-07-28	IMMP	0.00	-58.06	1.47
2026-07-29	IMMP	0.00	-58.06	1.47
2026-07-30	IMMP	0.00	-58.06	1.47
2026-07-31	IMMP	0.00	-58.06	1.47
2026-08-03	IMMP	0.00	-58.86	1.47
2026-08-04	IMMP	0.00	-58.86	1.47
2026-08-05	IMMP	0.00	-58.86	1.47
2026-08-06	IMMP	0.00	-58.86	1.47
2026-08-07	IMMP	0.00	-58.86	1.47
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-58.86

Beta

2.21

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

92.2

Max Drawdown 5-Year %

-93.6

Target Price

0.89

P/E

Forward P/E

PEG

P/S

21.29

P/B

0.86

P/Free Cash Flow

EPS

-0.37

Average EPS Est. Cur. Y

-0.32

EPS Next Y. (Est.)

-0.2

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-2026.12

Relative Volume

0.11

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-96.1

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.07

EBIT Estimation

61.3

◆ IMMP Healthcare

$0.39

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

17/25

Volume

11/15

Valuation

12/20

TP/AR

1/10

Options

7/10

RSI

44.6

Range 1M

23.5%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

10/30

Estimates

0/20

Inst/Vol

0/15

Options

5/10

EPS Yr

11.8%

EPS NY

55%

52W%

2.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +128.2% upside

Quality

5/30

Valuation

16/30

Growth

9/25

Stability

6/10

LT Trend

1/5

Upside

+128.2%

Quality

IMMP — P/E HistoricalBiotechnology

Immutep Limited

Sector: Healthcare

Industry: Biotechnology

Employees:

Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); INSIGHT-005 which is in phase I for metastatic urothelial carcinoma; TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. It also develops INSIGHT-003, which is in phase I trial 1L non squamous NSCL; INSIGHT-005 that is in phase I to treat metastatic urothelial cancer; IMP761, which is in phase I Trial to treat autoimmune disease; IMP731 for oncology and autoimmune diseases; and LAG525. Immutep has collaboration with Merck & Co., Inc., EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia.

IMMP

Latest News

—

Caricamento notizie per IMMP…

stock quote shares IMMP – Immutep Limited ADR Stock Price stock today

news today IMMP – Immutep Limited ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch IMMP – Immutep Limited ADR yahoo finance google finance

stock history IMMP – Immutep Limited ADR invest stock market

stock prices IMMP premarket after hours

ticker IMMP fair value insiders trading

GENE – Genetic Technologies Ltd. ADR

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=GENE #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

GENE — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.76

Target Price

6.87

Analyst Recom

Performance Q

-14.99

Upside

N/A

Beta

1.11

Ticker: GENE

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	GENE	0.765	N/A	N/A	0
2026-07-14	GENE	0.765	N/A	N/A	0
2026-07-15	GENE	0.765	N/A	N/A	0
2026-07-16	GENE	0.765	N/A	N/A	0
2026-07-17	GENE	0.765	N/A	N/A	0
2026-07-20	GENE	0.765	N/A	N/A	0
2026-07-21	GENE	0.765	N/A	N/A	0
2026-07-22	GENE	0.765	N/A	N/A	0
2026-07-23	GENE	0.765	N/A	N/A	0
2026-07-24	GENE	0.765	N/A	N/A	0
2026-07-27	GENE	0.765	N/A	N/A	0
2026-07-28	GENE	0.765	N/A	N/A	0
2026-07-29	GENE	0.765	N/A	N/A	0
2026-07-30	GENE	0.765	N/A	N/A	0
2026-07-31	GENE	0.765	N/A	N/A	0
2026-08-03	GENE	0.765	N/A	N/A	0
2026-08-04	GENE	0.765	N/A	N/A	0
2026-08-05	GENE	0.765	N/A	N/A	0
2026-08-07	GENE	0.765	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=GENE 589 360 ]

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

1.11

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.5

Max Drawdown 5-Year %

-97.7

Target Price

6.87

P/E

Forward P/E

PEG

P/S

1.24

P/B

2.89

P/Free Cash Flow

EPS

-1.83

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-156.76

Relative Volume

Return on Equity vs Sector %

-680.2

Return on Equity vs Industry %

-667.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=GENE 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=GENE 589 450 ]

No data found for GENE

GENE — P/E HistoricalDiagnostics & Research

[News_GENE _Stock]

stock quote shares GENE – Genetic Technologies Ltd. ADR Stock Price stock today

news today GENE – Genetic Technologies Ltd. ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch GENE – Genetic Technologies Ltd. ADR yahoo finance google finance

stock history GENE – Genetic Technologies Ltd. ADR invest stock market

stock prices GENE premarket after hours

ticker GENE fair value insiders trading

WDS – Woodside Energy Group Ltd

WDS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.19

Margin Of Safety %

Put/Call OI Ratio

0.23

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

22.43

Target Price

22.89

Analyst Recom

2.36

Performance Q

Upside

N/A

Beta

0.34

Ticker: WDS

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	WDS	20.53	0.19	0.04	16005
2026-07-14	WDS	21.04	0.19	0.65	16058
2026-07-15	WDS	20.88	0.19	0.10	16027
2026-07-16	WDS	20.59	0.18	1.70	16086
2026-07-17	WDS	21.73	0.18	0.08	16014
2026-07-20	WDS	21.65	0.22	0.44	9941
2026-07-21	WDS	22.24	0.22	0.00	9973
2026-07-22	WDS	22.42	0.21	0.21	10169
2026-07-23	WDS	22.33	0.21	5.91	10212
2026-07-24	WDS	22.57	0.22	0.00	10381
2026-07-27	WDS	21.81	0.21	31.33	10413
2026-07-28	WDS	22.16	0.25	0.01	10747
2026-07-29	WDS	23.23	0.22	0.20	12383
2026-07-30	WDS	23.4	0.23	0.03	12226
2026-07-31	WDS	23.46	0.23	0.06	12240
2026-08-03	WDS	22.7	0.23	0.07	12262
2026-08-04	WDS	22.44	0.23	0.04	12252
2026-08-05	WDS	22.02	0.23	1.47	12258
2026-08-07	WDS	22.41	0.23	2.40	12294
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	WDS	20.53	-	-	-
2026-07-14	WDS	21.04	-	-	-
2026-07-15	WDS	20.88	-	-	-
2026-07-16	WDS	20.60	-	-	-
2026-07-17	WDS	21.72	-	-	-
2026-07-20	WDS	21.64	-	-	-
2026-07-21	WDS	22.24	-	-	-
2026-07-22	WDS	22.43	-	-	-
2026-07-23	WDS	22.33	-	-	-
2026-07-24	WDS	22.57	-	-	-
2026-07-27	WDS	21.81	-	-	-
2026-07-28	WDS	22.17	-	-	-
2026-07-29	WDS	23.22	-	-	-
2026-07-30	WDS	23.41	-	-	-
2026-07-31	WDS	23.47	-	-	-
2026-08-03	WDS	22.72	-	-	-
2026-08-04	WDS	22.72	-	-	-
2026-08-05	WDS	22.01	-	-	-
2026-08-06	WDS	22.70	-	-	-
2026-08-07	WDS	22.43	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	WDS	0	-5.29	0.20
2026-07-14	WDS	0	-5.29	0.20
2026-07-15	WDS	0	-5.29	0.20
2026-07-16	WDS	0	-5.29	0.20
2026-07-17	WDS	0	-5.29	0.20
2026-07-20	WDS	0	-5.38	0.20
2026-07-21	WDS	0	-5.38	0.20
2026-07-22	WDS	0	-5.38	0.20
2026-07-23	WDS	0	-5.38	0.20
2026-07-24	WDS	0	-5.38	0.20
2026-07-27	WDS	0	-5.25	0.19
2026-07-28	WDS	0	-5.25	0.19
2026-07-29	WDS	0	-5.25	0.19
2026-07-30	WDS	0	-5.25	0.19
2026-07-31	WDS	0	-5.25	0.19
2026-08-03	WDS	0	-5.34	0.19
2026-08-04	WDS	0	-5.34	0.19
2026-08-05	WDS	0	-5.34	0.19
2026-08-06	WDS	0	-5.34	0.19
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-5.34

Beta

0.34

Average Sales Estimate Current Quarter

3613

Average Sales Estimate Next Quarter

3704

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

16.7

Max Drawdown 5-Year %

-48.8

Target Price

22.89

P/E

15.96

Forward P/E

PEG

5.44

P/S

3.32

P/B

1.2

P/Free Cash Flow

EPS

1.42

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

20.97

Relative Volume

0.52

Return on Equity vs Sector %

-3.6

Return on Equity vs Industry %

-6.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

No data found for WDS

WDS — P/E HistoricalOil & Gas E&P

Woodside Energy Group Limited

Sector: Energy

Industry: Oil & Gas E&P

Employees: 4693

Woodside Energy Group Ltd engages in the exploration, evaluation, development, production, marketing, and sale of hydrocarbons in the Asia Pacific, Africa, the Americas, and the Europe. It produces liquefied natural gas, pipeline gas, crude oil and condensate, and natural gas liquids. The company holds interests in the Pluto LNG, North West Shelf, Wheatstone and Julimar-Brunello, Bass Strait, Ngujima-Yin FPSO, Okha FPSO, Pyrenees FPSO, Macedon, Shenzi, Mad dog, Greater Angostura, as well as Scarborough, Sangomar, Trion, Calypso, Browse, Liard, Ruby, Sangomar, Atlantis, Woodside Solar opportunity, and Sunrise and Troubadour. It is also involved in the development of new energy products and lower-carbon services. The company was formerly known as Woodside Petroleum Ltd and changed its name to Woodside Energy Group Ltd in May 2022. Woodside Energy Group Ltd was founded in 1954 and is headquartered in Perth, Australia.

WDS

Latest News

—

Caricamento notizie per WDS…

stock quote shares WDS – Woodside Energy Group Ltd Stock Price stock today

news today WDS – Woodside Energy Group Ltd stock forecast ,stock prediction 2023 2024 2025

marketwatch WDS – Woodside Energy Group Ltd yahoo finance google finance

stock history WDS – Woodside Energy Group Ltd invest stock market

stock prices WDS premarket after hours

ticker WDS fair value insiders trading

BHP – BHP Group Limited

BHP — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.62

Margin Of Safety %

-14

Put/Call OI Ratio

0.97

EPS Next Q Diff

EPS Last/This Y

1.52

EPS This/Next Y

-0.21

Price

90.43

Target Price

72.5

Analyst Recom

3.12

Performance Q

Upside

56.0%

Beta

0.9

Ticker: BHP

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	BHP	81.39	0.59	0.78	121910
2026-07-14	BHP	84.34	0.59	2.99	122947
2026-07-15	BHP	85.49	0.58	0.97	123074
2026-07-16	BHP	80.67	0.61	1.96	125928
2026-07-17	BHP	80.63	0.63	1.39	126445
2026-07-20	BHP	80.51	0.62	0.35	115017
2026-07-21	BHP	83.46	0.62	3.75	115519
2026-07-22	BHP	84.53	0.64	1.42	117999
2026-07-23	BHP	83.66	0.65	2.50	119073
2026-07-24	BHP	83.74	0.66	1.66	120304
2026-07-27	BHP	83.9	0.67	2.28	121146
2026-07-28	BHP	83.78	0.68	1.49	122210
2026-07-29	BHP	83.14	0.69	24.97	123103
2026-07-30	BHP	85.89	1.10	3.51	153538
2026-07-31	BHP	84.44	1.13	1.95	157362
2026-08-03	BHP	83.49	1.14	0.89	157888
2026-08-04	BHP	87.47	1.12	0.29	160025
2026-08-05	BHP	89.39	1.05	0.96	168845
2026-08-06	BHP	87.87	1.05	0.11	170231
2026-08-07	BHP	90.43	0.97	0.45	178945
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	BHP	81.39	-	2185.1	5.10
2026-07-14	BHP	84.36	-	3027.3	5.10
2026-07-15	BHP	85.49	-	3200.1	5.10
2026-07-16	BHP	80.71	-	1099.2	5.10
2026-07-17	BHP	80.60	-	2534.7	5.10
2026-07-20	BHP	80.50	-	3127.1	5.10
2026-07-21	BHP	83.46	-	4031.5	5.10
2026-07-22	BHP	84.56	-	3643.8	5.10
2026-07-23	BHP	83.66	-	2765.4	5.10
2026-07-24	BHP	83.72	-	2470.7	5.10
2026-07-27	BHP	83.93	-	3339.7	5.10
2026-07-28	BHP	83.79	-	2688.4	5.10
2026-07-29	BHP	83.09	-	1763.9	5.10
2026-07-30	BHP	85.90	-	2271.8	4.98
2026-07-31	BHP	84.46	-	2333.2	5.08
2026-08-03	BHP	83.52	-	1392.6	5.08
2026-08-04	BHP	83.52	-	1392.6	5.08
2026-08-05	BHP	89.38	-	3020.3	5.08
2026-08-06	BHP	87.89	-	2088.4	5.08
2026-08-07	BHP	90.43	-	1571.7	5.08
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	BHP	0	-10.36	0.71
2026-07-14	BHP	0	-10.36	0.71
2026-07-15	BHP	0	-10.36	0.71
2026-07-16	BHP	0	-10.36	0.71
2026-07-17	BHP	0	-10.36	0.71
2026-07-20	BHP	0	-10.17	0.71
2026-07-21	BHP	0	-10.17	0.71
2026-07-22	BHP	0	-10.17	0.71
2026-07-23	BHP	0	-10.17	0.71
2026-07-24	BHP	0	-10.17	0.71
2026-07-27	BHP	0	-10.11	0.62
2026-07-28	BHP	0	-10.11	0.62
2026-07-29	BHP	0	-10.11	0.62
2026-07-30	BHP	0	-10.11	0.62
2026-07-31	BHP	0	-10.11	0.62
2026-08-03	BHP	0	-10.14	0.62
2026-08-04	BHP	0	-10.14	0.62
2026-08-06	BHP	0	-10.14	0.62
2026-08-07	BHP	0	-10.14	0.62
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-10.14

Beta

0.9

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

77.87

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

3.6

Max Drawdown 5-Year %

-37.2

Target Price

72.5

P/E

22.42

Forward P/E

18.05

PEG

2.63

P/S

4.25

P/B

4.55

P/Free Cash Flow

22.28

EPS

4.03

Average EPS Est. Cur. Y

5.08

EPS Next Y. (Est.)

4.87

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

18.97

Relative Volume

0.9

Return on Equity vs Sector %

3.7

Return on Equity vs Industry %

2.6

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.12

EBIT Estimation

1571.7

◆ BHP Basic Materials

$90.41

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

8/25

Volume

7/15

Valuation

5/20

TP/AR

2/10

Options

2/10

RSI

Range 1M

99.7%

Sup Dist

3.5%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

20/25

Growth

11/30

Estimates

6/20

Inst/Vol

1/15

Options

4/10

EPS Yr

25.2%

52W%

92.1%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +36.1% upside

Quality

17/30

Valuation

11/30

Growth

10/25

Stability

4/10

LT Trend

4/5

Upside

+36.1%

Quality

MoS

-14%

BHP — P/E HistoricalOther Industrial Metals & Mining

BHP Group Limited

Sector: Basic Materials

Industry: Other Industrial Metals & Mining

Employees: 39369

BHP Group Limited operates as a resources company in Australia, Europe, China, Japan, India, South Korea, rest of Asia, North America, South America, and internationally. The company operates through Copper, Iron Ore, and Coal segments. It also engages in the mining of copper, uranium, gold, zinc, lead, molybdenum, silver, iron ore, cobalt, and metallurgical and energy coal. In addition, the company is involved in the mining, smelting, and refining of nickel, as well as potash development activities. Further, it provides towing, freight, marketing and trading, marketing support, finance, administrative, and other services. BHP Group Limited was founded in 1851 and is headquartered in Melbourne, Australia.

BHP

Latest News

—

Caricamento notizie per BHP…

stock quote shares BHP – BHP Group Limited Stock Price stock today

news today BHP – BHP Group Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch BHP – BHP Group Limited yahoo finance google finance

stock history BHP – BHP Group Limited invest stock market

stock prices BHP premarket after hours

ticker BHP fair value insiders trading

No more stocks to show

IREN – IREN Ltd

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: IREN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

IMRN – Immuron Limited ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: IMRN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y